BF Biosciences Limited (PSX:BFBIO)
Pakistan flag Pakistan · Delayed Price · Currency is PKR
130.90
-1.72 (-1.30%)
At close: Nov 6, 2026

BF Biosciences Financials Overview

Millions PKR. Fiscal year is Jul - Jun.

Revenue & Profits

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Revenue
9,8139,4615,8373,6591,8101,521
Revenue Growth
42.56%62.08%59.55%102.19%18.99%-13.34%
Gross Profit
4,3224,0762,2851,531447.24457.77
Operating Income
1,1171,087731.69709.65269.29242.23
Net Income
657.49632.13447.15385.41149.05306.98
Earnings Per Share
7.447.165.526.092.354.85
EPS Growth
31.94%29.53%-9.21%158.57%-51.45%-49.51%

Revenue by Geography

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Jun '25 Jun '24 Jun '23 Jun '22
Pakistan
9,3145,7243,6061,7691,049
Nepal
40.6939.0833.8930.49-
Cambodia
26.91----
Uzbekistan
17.3----
Kenya
18.65----
Afghanistan
11.0332.51---
Mauritania
11.3717.8---
Switzerland
6.6916.82---
Sri Lanka
4.24-8.445.72-
Others
10.647.619.94.72-
Total
9,4615,8373,6591,8101,520

Cash & Debt

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Cash & Investments
589.27572.771,511317.78402.831,710
Total Debt
1,6591,6141,7252,2122,6031,744
Net Cash (Debt)
-1,070-1,041-213.54-1,894-2,200-34.26
Net Cash Growth
------
Net Cash Per Share
-12.10-11.78-2.64-29.91-34.74-0.54

Cash Flow & CapEx

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Operating Cash Flow
171.8-26.51299.79664.7-196.07178
Capital Expenditures
-854.54-603.06-324.37-143.13-1,968-1,130
Free Cash Flow
-682.75-629.57-24.59521.57-2,164-952
Free Cash Flow Growth
------

Margins

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Gross Margin
44.05%43.08%39.13%41.84%24.72%30.10%
Operating Margin
11.38%11.49%12.53%19.40%14.88%15.93%
Pretax Margin
11.14%11.28%12.40%15.90%11.17%22.93%
Profit Margin
6.70%6.68%7.66%10.53%8.24%20.19%
FCF Margin
-6.96%-6.65%-0.42%14.26%-119.61%-62.60%

Valuation

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingNov '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
PE Ratio
17.6019.9733.33---
Forward PE
-22.5722.57---
PS Ratio
1.181.332.55---